135 related articles for article (PubMed ID: 32316076)
1. The prognostic effect of smoking status on intensively treated acute myeloid leukaemia - A Danish nationwide cohort study.
Kristensen D; Nielsen LB; Roug AS; Kristensen TC; El-Galaly TC; Nørgaard JM; Marcher CW; Schöllkopf C; Theilgaard-Mönch K; Severinsen MT
Br J Haematol; 2020 Jul; 190(2):236-243. PubMed ID: 32316076
[TBL] [Abstract][Full Text] [Related]
2. Smoking and subsequent risk of acute myeloid leukaemia: A pooled analysis of 9 cohort studies in Japan.
Ugai T; Matsuo K; Oze I; Ito H; Wakai K; Wada K; Nagata C; Nakayama T; Liu R; Kitamura Y; Tamakoshi A; Tsuji I; Sugawara Y; Sawada N; Sadakane A; Tanaka K; Mizoue T; Inoue M; Tsugane S; Shimazu T;
Hematol Oncol; 2018 Feb; 36(1):262-268. PubMed ID: 28681440
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of cigarette smoking on survival in acute myeloid leukemia with TP53 mutations and/or 17p deletions.
Bi X; French Z; Palmisiano N; Wen KY; Wilde L
Ann Hematol; 2022 Jun; 101(6):1251-1259. PubMed ID: 35288759
[TBL] [Abstract][Full Text] [Related]
4. Influence of cigarette smoking on the presentation and course of acute myeloid leukemia.
Chelghoum Y; Danaïla C; Belhabri A; Charrin C; Le QH; Michallet M; Fiere D; Thomas X
Ann Oncol; 2002 Oct; 13(10):1621-7. PubMed ID: 12377652
[TBL] [Abstract][Full Text] [Related]
5. Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry.
Glintborg B; Højgaard P; Lund Hetland M; Steen Krogh N; Kollerup G; Jensen J; Chrysidis S; Jensen Hansen IM; Holland-Fischer M; Højland Hansen T; Nilsson C; Espesen J; Nordin H; Rasmussen Loft AG; Pelck R; Lorenzen T; Flejsborg Oeftiger S; Unger B; Jaeger F; Mosborg Petersen P; Rasmussen C; Dreyer L
Rheumatology (Oxford); 2016 Apr; 55(4):659-68. PubMed ID: 26628579
[TBL] [Abstract][Full Text] [Related]
6. Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study.
Østgård LSG; Nørgaard M; Medeiros BC; Friis LS; Schoellkopf C; Severinsen MT; Marcher CW; Nørgaard JM
J Clin Oncol; 2017 Nov; 35(32):3678-3687. PubMed ID: 28892433
[TBL] [Abstract][Full Text] [Related]
7. Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patients.
Østgård LS; Nørgaard M; Sengeløv H; Medeiros BC; Kjeldsen L; Overgaard UM; Severinsen MT; Marcher CW; Jensen MK; Nørgaard JM
Oncotarget; 2016 Nov; 7(44):72044-72056. PubMed ID: 27732947
[TBL] [Abstract][Full Text] [Related]
8. Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000-2016: a Danish population-based study.
Hjort Jakobsen L; Stidsholt Roug A; Kiesbye Øvlisen A; Werenberg Marcher C; Beier Ommen H; Theilgaard-Mönch K; Møller P; Schöllkopf C; Kristensen D; Maria Henriette Naur T; Bøgsted M; Christoffer El-Galaly T; Tang Severinsen M
Br J Haematol; 2021 May; 193(3):482-487. PubMed ID: 33222154
[TBL] [Abstract][Full Text] [Related]
9. Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.
Seymour JF; Döhner H; Butrym A; Wierzbowska A; Selleslag D; Jang JH; Kumar R; Cavenagh J; Schuh AC; Candoni A; Récher C; Sandhu I; Del Castillo TB; Al-Ali HK; Falantes J; Stone RM; Minden MD; Weaver J; Songer S; Beach CL; Dombret H
BMC Cancer; 2017 Dec; 17(1):852. PubMed ID: 29241450
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse.
Lim ABM; Curley C; Fong CY; Bilmon I; Beligaswatte A; Purtill D; Getta B; Johnston AM; Armytage T; Collins M; Mason K; Fielding K; Greenwood M; Gibson J; Hertzberg M; Wright M; Lewis I; Moore J; Curtis D; Szer J; Kennedy G; Ritchie D
Intern Med J; 2018 Mar; 48(3):276-285. PubMed ID: 28628276
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
[TBL] [Abstract][Full Text] [Related]
12. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
13. Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Østgård LSG; Lund JL; Nørgaard JM; Nørgaard M; Medeiros BC; Nielsen B; Nielsen OJ; Overgaard UM; Kallenbach M; Marcher CW; Riis AH; Sengeløv H
Biol Blood Marrow Transplant; 2018 Feb; 24(2):314-323. PubMed ID: 29051022
[TBL] [Abstract][Full Text] [Related]
14. Outcome and late effects among acute myeloid leukemia survivors: a nationwide population-based study.
Chang KH; Hwang WL; Muo CH; Hsu CY; Teng CJ
Support Care Cancer; 2016 Dec; 24(12):4993-5000. PubMed ID: 27502072
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia.
Fu Y; Xu M; Cui Z; Yang Z; Zhang Z; Yin X; Huang X; Zhou M; Wang X; Chen C
EBioMedicine; 2020 Feb; 52():102664. PubMed ID: 32062360
[TBL] [Abstract][Full Text] [Related]
16. Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.
Bhatt VR; Batra R; Silberstein PT; Loberiza FR; Ganti AK
Med Oncol; 2015 Jan; 32(1):339. PubMed ID: 25429831
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Parameters of Acute Myeloid Leukaemia at Presentation.
Jahic A; Iljazovic E; Hasic S; Arnautovic AC; Sabitovic D; Mesanovic S; Sahovic H; Simendic V
Med Arch; 2017 Feb; 71(1):20-24. PubMed ID: 28428668
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.
Ornstein MC; Mukherjee S; Mohan S; Elson P; Tiu RV; Saunthararajah Y; Kendeigh C; Advani A; Kalaycio M; Maciejewski JP; Sekeres MA
Am J Hematol; 2014 Feb; 89(2):168-73. PubMed ID: 24123154
[TBL] [Abstract][Full Text] [Related]
19. The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies.
Fircanis S; Merriam P; Khan N; Castillo JJ
Am J Hematol; 2014 Aug; 89(8):E125-32. PubMed ID: 24753145
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
